Delivery Order SPE2DB20D1109-SPE2DB25FP17H
- Not listed
- The Defense Logistics Agency awarded a $33,133.71 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Wezlana 90 mg/ml syringes. This firm fixed price delivery order, with an ultimate completion date of September 15, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $17,011.92 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Wezlana 90 mg/ml syringes. This firm fixed price contract, with an ultimate completion date of July 25, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open competition with no set-aside designation...
- The Defense Logistics Agency awarded a $16,577.11 delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of Wezlana 90 mg/mL syringes. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of July 14, 2025, and represents a child delivery order under a larger contract vehicle. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award....
- The Defense Logistics Agency awarded a $71,048.38 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Wezlana 90 mg/mL syringes. The contract utilizes firm fixed pricing and carries an ultimate completion date of June 20, 2025. This competitively awarded delivery order was issued without a set-aside designation and will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract...
- The Defense Logistics Agency awarded a delivery order valued at $17,290.48 to AmerisourceBergen Drug Corp for the supply of Wezlana 90 mg/mL syringes. The contract is a firm fixed price delivery order with an ultimate completion date of June 20, 2025, and was awarded on June 18, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the vendor's...
- The Defense Logistics Agency awarded a $15,801.47 delivery order to AmerisourceBergen Drug Corp for Wezlana 90 mg/mL syringes on August 18, 2025, with completion targeted for August 19, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $82,826.37 to AmerisourceBergen Drug Corp for the supply of Wezlana 90 mg/ml syringes, with an ultimate completion date of September 9, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on September 8, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a $10,048.89 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Wezlana 90 mg/ml syringes. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 20, 2025. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $70,310.56 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Wezlana 90 mg/mL syringes. This contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive award. The ultimate completion date is September 4, 2025, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,540.76 to AmerisourceBergen Drug Corp for the supply of Wezlana 90 mg/mL syringes. This competitive delivery order, issued on August 7, 2025, with an ultimate completion date of August 8, 2025, utilizes firm fixed pricing and carries no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP17HDelivery Order
The Defense Logistics Agency awarded a $20,125.87 delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Wezlana 90 mg/ml syringes. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The order is scheduled for completion by June 4, 2025, with performance to occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen leverages this comprehensive IDC vehicle to supply a broad range of pharmaceutical products and medical supplies to military healthcare systems and the Defense Health Agency. The company's demonstrated capability to fulfill competitive federal medical supply requirements, combined with its extensive pharmaceutical portfolio, positions it as a critical vendor supporting global military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.1k | 6/3/25 |